---
schema_version: "secwatch.filing_event.v1"
accession: "0001801170-23-000004"
form_type: "8-K"
ticker: "CLOV"
cik: "0001801170"
company_name: "CLOVER HEALTH INVESTMENTS, CORP. /DE"
filed_at: "2023-01-10T23:59:59+00:00"
generated_at: "2026-06-20T17:13:32.751520+00:00"
event_type: "leadership"
sentiment: "positive"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Clover Health appoints Jamie Reynoso as CEO of Medicare Advantage and issues FY2023 partial guidance

## Summary
- Appointed Jamie L. Reynoso as Chief Executive Officer of Medicare Advantage, effective January 6, 2023.
- Issued partial FY2023 guidance: Insurance revenue $1.15B-$1.20B, Insurance MCR 89%-91%.
- Andrew Toy to present at 41st Annual J.P. Morgan Healthcare Conference on January 11, 2023.
- Non-Insurance revenue guidance $0.75B-$0.80B, Non-Insurance MCR 98%-100%.
- Strategic shift to prioritize profitability, expecting favorability in 2023 MCR and growth in Insurance top-line revenue.

## SEC filing metadata
- accession: 0001801170-23-000004
- form_type: 8-K
- ticker: CLOV
- cik: 0001801170
- company_name: CLOVER HEALTH INVESTMENTS, CORP. /DE
- filed_at: 2023-01-10T23:59:59+00:00
- event_type: leadership
- sentiment: positive
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1801170/000180117023000004/0001801170-23-000004-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1801170/000180117023000004/clov-20230106.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001801170-23-000004
- JSON: https://secwatch.observer/filing/0001801170-23-000004.json
- Plain text: https://secwatch.observer/filing/0001801170-23-000004.txt

## Key facts
- Executive change
  Jamie L. Reynoso was appointed as Chief Executive Officer of Medicare Advantage at CLOVER HEALTH INVESTMENTS, CORP. /DE.
  - Action: appointed
  - Role: Chief Executive Officer of Medicare Advantage
  source text: On January 6, 2023, the Board of Directors of Clover Health Investments, Corp. (the " Company ") appointed Jamie L. Reynoso Chief Executive Officer of Medicare Advantage, effective immediately.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1801170/000180117023000004/0001801170-23-000004-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.